Clinical cases of the treatment of metastatic colorectal cancer in Russia

V E Goldberg; A I Hasanova; V V Shkuratova; Yu V Belevich; N O Popova; E I Simolina; V V Vysockaya; E A Dudnikova; T L Kravchuk; R R Minnabetdinova; O V Nekrasova

Современная онкология (Dec 2017)

Clinical cases of the treatment of metastatic colorectal cancer in Russia

V E Goldberg,
A I Hasanova,
V V Shkuratova,
Yu V Belevich,
N O Popova,
E I Simolina,
V V Vysockaya,
E A Dudnikova,
T L Kravchuk,
R R Minnabetdinova,
O V Nekrasova

Affiliations

V E Goldberg: Research Institute of Oncology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
A I Hasanova: Republican Clinical Oncologic Dispensary
V V Shkuratova: Multidisciplinary Clinical Medical Center “Medical city”
Yu V Belevich: Research Institute of Oncology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
N O Popova: Research Institute of Oncology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
E I Simolina: Research Institute of Oncology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
V V Vysockaya: Research Institute of Oncology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
E A Dudnikova: Research Institute of Oncology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
T L Kravchuk: Research Institute of Oncology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
R R Minnabetdinova: Republican Clinical Oncologic Dispensary
O V Nekrasova: Multidisciplinary Clinical Medical Center “Medical city”

Journal volume & issue: Vol. 19, no. 4
pp. 39 – 44

Abstract

Read online

The article presents the clinical cases of the targeted therapy regorafenib in metastatic colorectal cancer (mCRC) in Russia. Russian oncologists’ experience has not only confirmed the results of international clinical trials, but also clearly demonstrated the possibility of regorafenib long-term administration on the back of high efficacy and manageable safety profile.

Published in Современная онкология

ISSN: 1815-1434 (Print); 1815-1442 (Online)
Publisher: IP Habib O.N.
Country of publisher: Russian Federation
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://modernonco.orscience.ru/

About the journal

Abstract

Keywords